The Absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation

Gerhard C. Hildebrandt, Sung W. Choi, Gunnar Mueller, Krystyna M. Olkiewicz, Bethany B. Moore, Kenneth R Cooke

Research output: Contribution to journalArticle

Abstract

Acute graft versus host disease (aGVHD) after allogeneic bone marrow transplantation (allo-BMT) predominantly involves a Th1-type cytokine response. Interestingly, the Th2-cytokine, Interleukin-13 (IL-13), produced by alloreactive donor T cells in vitro was recently shown to correlate with clinical aGVHD severity. Using an established mouse model, we show that the systemic cytokine milieu following allo-BMT with IL-13-/- donors is characterized by decreases in serum Th2 cytokines and an increase in serum TNFα, and ultimately correlates with higher aGVHD mortality compared to allogeneic controls. In vitro studies further demonstrate that both exogenous and T cell-derived IL-13 can regulate TNFα production by macrophages following lipopolysaccharide stimulation. Thus, donor-derived IL-13 may have a role in modulating inflammatory cytokine release that is associated with aGVHD.

Original languageEnglish (US)
Pages (from-to)911-914
Number of pages4
JournalPediatric Blood and Cancer
Volume50
Issue number4
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Interleukin-13
Homologous Transplantation
Graft vs Host Disease
Bone Marrow Transplantation
Cytokines
T-Lymphocytes
Serum
Lipopolysaccharides
Macrophages
Mortality

Keywords

  • Acute GVHD
  • Cytokines
  • IL-13
  • T cell
  • Tumor necrosis factor a

ASJC Scopus subject areas

  • Cancer Research
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

The Absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation. / Hildebrandt, Gerhard C.; Choi, Sung W.; Mueller, Gunnar; Olkiewicz, Krystyna M.; Moore, Bethany B.; Cooke, Kenneth R.

In: Pediatric Blood and Cancer, Vol. 50, No. 4, 04.2008, p. 911-914.

Research output: Contribution to journalArticle

Hildebrandt, Gerhard C. ; Choi, Sung W. ; Mueller, Gunnar ; Olkiewicz, Krystyna M. ; Moore, Bethany B. ; Cooke, Kenneth R. / The Absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation. In: Pediatric Blood and Cancer. 2008 ; Vol. 50, No. 4. pp. 911-914.
@article{6f58893fb4f1435692452d4e95e2ae80,
title = "The Absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation",
abstract = "Acute graft versus host disease (aGVHD) after allogeneic bone marrow transplantation (allo-BMT) predominantly involves a Th1-type cytokine response. Interestingly, the Th2-cytokine, Interleukin-13 (IL-13), produced by alloreactive donor T cells in vitro was recently shown to correlate with clinical aGVHD severity. Using an established mouse model, we show that the systemic cytokine milieu following allo-BMT with IL-13-/- donors is characterized by decreases in serum Th2 cytokines and an increase in serum TNFα, and ultimately correlates with higher aGVHD mortality compared to allogeneic controls. In vitro studies further demonstrate that both exogenous and T cell-derived IL-13 can regulate TNFα production by macrophages following lipopolysaccharide stimulation. Thus, donor-derived IL-13 may have a role in modulating inflammatory cytokine release that is associated with aGVHD.",
keywords = "Acute GVHD, Cytokines, IL-13, T cell, Tumor necrosis factor a",
author = "Hildebrandt, {Gerhard C.} and Choi, {Sung W.} and Gunnar Mueller and Olkiewicz, {Krystyna M.} and Moore, {Bethany B.} and Cooke, {Kenneth R}",
year = "2008",
month = "4",
doi = "10.1002/pbc.21228",
language = "English (US)",
volume = "50",
pages = "911--914",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - The Absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation

AU - Hildebrandt, Gerhard C.

AU - Choi, Sung W.

AU - Mueller, Gunnar

AU - Olkiewicz, Krystyna M.

AU - Moore, Bethany B.

AU - Cooke, Kenneth R

PY - 2008/4

Y1 - 2008/4

N2 - Acute graft versus host disease (aGVHD) after allogeneic bone marrow transplantation (allo-BMT) predominantly involves a Th1-type cytokine response. Interestingly, the Th2-cytokine, Interleukin-13 (IL-13), produced by alloreactive donor T cells in vitro was recently shown to correlate with clinical aGVHD severity. Using an established mouse model, we show that the systemic cytokine milieu following allo-BMT with IL-13-/- donors is characterized by decreases in serum Th2 cytokines and an increase in serum TNFα, and ultimately correlates with higher aGVHD mortality compared to allogeneic controls. In vitro studies further demonstrate that both exogenous and T cell-derived IL-13 can regulate TNFα production by macrophages following lipopolysaccharide stimulation. Thus, donor-derived IL-13 may have a role in modulating inflammatory cytokine release that is associated with aGVHD.

AB - Acute graft versus host disease (aGVHD) after allogeneic bone marrow transplantation (allo-BMT) predominantly involves a Th1-type cytokine response. Interestingly, the Th2-cytokine, Interleukin-13 (IL-13), produced by alloreactive donor T cells in vitro was recently shown to correlate with clinical aGVHD severity. Using an established mouse model, we show that the systemic cytokine milieu following allo-BMT with IL-13-/- donors is characterized by decreases in serum Th2 cytokines and an increase in serum TNFα, and ultimately correlates with higher aGVHD mortality compared to allogeneic controls. In vitro studies further demonstrate that both exogenous and T cell-derived IL-13 can regulate TNFα production by macrophages following lipopolysaccharide stimulation. Thus, donor-derived IL-13 may have a role in modulating inflammatory cytokine release that is associated with aGVHD.

KW - Acute GVHD

KW - Cytokines

KW - IL-13

KW - T cell

KW - Tumor necrosis factor a

UR - http://www.scopus.com/inward/record.url?scp=40449085042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449085042&partnerID=8YFLogxK

U2 - 10.1002/pbc.21228

DO - 10.1002/pbc.21228

M3 - Article

C2 - 17455319

AN - SCOPUS:40449085042

VL - 50

SP - 911

EP - 914

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 4

ER -